NASDAQ: REGNRegeneron Pharmaceuticals Inc Stock Ownership - Who owns Regeneron Pharmaceuticals?
Insider buying vs selling
Have Regeneron Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Arthur F. Ryan | Director | 2026-05-01 | 24 | $703.46 | $16.88kSell |
| Arthur F. Ryan | Director | 2026-05-01 | 14 | $705.56 | $9.88kSell |
| Arthur F. Ryan | Director | 2026-05-01 | 7 | $706.74 | $4.95kSell |
| Arthur F. Ryan | Director | 2026-05-01 | 4 | $707.40 | $2.83kSell |
| Arthur F. Ryan | Director | 2026-05-01 | 6 | $709.45 | $4.26kSell |
| Arthur F. Ryan | Director | 2026-05-01 | 2 | $710.87 | $1.42kSell |
| Arthur F. Ryan | Director | 2026-05-01 | 5 | $711.49 | $3.56kSell |
| Arthur F. Ryan | Director | 2026-05-01 | 1 | $712.09 | $712.09Sell |
| Arthur F. Ryan | Director | 2026-05-01 | 2 | $714.13 | $1.43kSell |
| Arthur F. Ryan | Director | 2026-05-01 | 15 | $704.28 | $10.56kSell |
REGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when REGN insiders and whales buy or sell their stock.
REGN Shareholders
What type of owners hold Regeneron Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Sanofi | 34.83% | 36,518,618 | $22.27B | Insider |
| Blackrock Inc | 8.53% | 8,947,735 | $5.46B | Institution |
| Vanguard Capital Management LLC | 6.35% | 6,654,913 | $4.06B | Institution |
| State Street Corp | 4.45% | 4,664,478 | $2.85B | Institution |
| Dodge Cox | 4.25% | 4,458,238 | $2.72B | Institution |
| Jpmorgan Chase Co | 4.11% | 4,311,806 | $2.63B | Institution |
| Franklin Resources Inc | 2.60% | 2,722,071 | $1.66B | Institution |
| Geode Capital Management LLC | 2.49% | 2,607,732 | $1.59B | Institution |
| Price T Rowe Associates Inc | 2.08% | 2,177,527 | $1.33B | Institution |
| Nuveen LLC | 1.97% | 2,065,064 | $1.26B | Institution |
REGN vs Biotech Stocks
Regeneron Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.